Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes

Anemia is the most common symptom in patients with myelodysplastic syndromes (MDS). Programmed cell death of erythrocytes is one of the contributing factors to anemia. Ferroptosis is a newly identified form of iron-dependent cell death. The aim of this study is to investigate whether anemia in MDS patients is associated with Ferroptosis of nucleated erythrocytes(NEs).We detected lipid peroxidation levels, Fe²⁺ contents, cell death rates, glutathione (GSH) and malondialdehyde (MDA) levels in bone marrow CD235a⁺ NEs of MDS patients. Expression levels of ferroptosis-related molecules (ACSL4, GPX4, and SLC7A11) were evaluated through qRT-PCR and Western Blotting. Correlation between these markers and clinical parameters were analyzed. To further substantiate that the mode of cell death with CD235a⁺ NEs of MDS patients was attributed to the Ferroptosis pathway, we applied Fer-1 to inhibit Ferroptosis. Cell viability was assessed using CCK8, and changes in ferroptosis-related indicators were simultaneously evaluated. We discover that the Ferroptosis level of bone marrow NEs in MDS patients was increased, which is related to anemia and iron overload. Ferroptosis might be one of the causes of anemia in MDS patients.

Anemia; Erythrocytes; Ferroptosis; Myelodysplastic syndromes.